Clinical Trial Update: Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. [Phase 1, Phase 2]

View source ↗

Summary

A multicenter Phase 1/2 trial evaluated adipose-derived mesenchymal stem cells for chronic graft-versus-host disease and is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Adipose-derived mesenchymal stem cell therapy (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED